Trial Profile
Clinical Pharmacology, Efficacy and Safety Study of FGTW in Paediatric Patients With Severe Congenital Fibrinogen Deficiency
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 04 Apr 2022
Price :
$35
*
At a glance
- Drugs Fibrinogen (Primary)
- Indications Afibrinogenaemia; Blood coagulation disorders
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors LFB Biotechnologies
- 11 May 2020 Results published in the Thrombosis and Haemostasis
- 08 Jul 2014 New trial record